Bruno Bruins
Directeur/Membre du Conseil chez Institute for Translational Vaccinology
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Jan Groen | M | 65 |
Intravacc BV
| - |
Karin Louise Dorrepaal | M | 63 |
Institute for Translational Vaccinology
Institute for Translational Vaccinology BiotechnologyHealth Technology Institute for Translational Vaccinology is a Dutch independent company that partners with clients in vaccine development, from discovery to pilot production to clinical studies. The non-profit company is based in Bilthoven, Netherlands. Intravacc designs and creates the best candidate organisms for vaccine strain, looking for the highest immunity, potency, and production yield. The company substantially reduces the risks and costs involved with developing vaccines by bridging the gap between concept and late-stage clinical studies. Intravacc's upstream processing expertise covers both bacterial and cell cultivation as well as virus propagation in reactors ranging from 1l up to 200l. The company's scientists design, develop, and improve vaccine formulations that are suitable for the intended administration route and stable upon storage.
Intravacc BV
| 3 ans |
Nathalie Laarakker | F | - |
Intravacc BV
| 3 ans |
Erik Popping | M | - |
Intravacc BV
| 8 ans |
Nico Oudendijk | M | - |
Intravacc BV
| - |
Daniëlle Lankveld | M | - |
Intravacc BV
| 11 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Pays-Bas | 6 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Bruno Bruins
- Réseau Personnel